Marco Matucci Cerinic
0000-0002-9324-3161
14 papers found
Refreshing results…
Retention rates of different Janus kinase inhibitors in rheumatoid arthritis: experience from a large monocentric cohort
Secukinumab is not associated with cancer recurrence or progression in patients with spondyloarthritis and history of neoplastic disease
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry ‘SPRING’ of the Italian Society for Rheumatology
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study
Cardiovascular magnetic resonance in autoimmune rheumatic diseases: a clinical consensus document by the European Association of Cardiovascular Imaging
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies
Managing inadequate response to initial anti-TNF therapy in rheumatoid arthritis: optimising treatment outcomes
Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire
Peripheral neuropathy in systemic lupus erythematosus: what can neuromuscular ultrasonography (NMUS) tell us? A cross-sectional study
Pulmonary arterial hypertension: guidelines and unmet clinical needs
Response to: ‘Correspondence on ‘Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management’’ by Snarskaya and Vasileva
Infection or autoimmunity? The clinical challenge of interstitial lung disease in systemic sclerosis during COVID 19 pandemic
COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs
The challenge of Very Early Systemic Sclerosis: a Combination of Mild and Early Disease?
Missing publications? Search for publications with a matching author name.